YiChang opens for orders on HK listing
YiChang HEC ChangJiang Pharmaceutical Co has opened books for a float of HK$1.67bn ($215m), kicking off the process with a renowned pharma investor among the cornerstones.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts